BIOVIC B — Biovica International AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Biovica International AB, fiscal year end - April 30th, SEK millions except per share, conversion factor applied.

	2019 April 30th	2020 April 30th	2021 April 30th	2022 April 30th	2023 April 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3	1.67	2.08	2.04	3.38
Cost of Revenue
Gross Profit	9.51	8.71	5.64	5.04	4.96
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	24.7	31.5	42.3	62.1	114
Operating Profit	-21.7	-29.8	-40.2	-60.1	-110
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-21.5	-30.3	-39.4	-60	-111
Provision for Income Taxes
Net Income After Taxes	-21.6	-30.3	-39.5	-60	-110
Net Income Before Extraordinary Items
Net Income	-21.6	-30.3	-39.5	-60	-110
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-21.6	-30.3	-39.5	-60	-110
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.14	-1.2	-1.29	-1.96	-2.98
Dividends per Share